A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
- PMID: 41468073
- DOI: 10.1097/OGX.0000000000001463
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
Abstract
(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Comment on
-
A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.N Engl J Med. 2025 May 8;392(18):1801-1812. doi: 10.1056/NEJMoa2415948. Epub 2025 Mar 19. N Engl J Med. 2025. PMID: 40105270 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
